Keywords: cml, treatment, sprycel, launched, uk, usa-based, drug

CML treatment Sprycel launched in UK

Article | 11 December 2006

Print This

USA-based drug major Bristol-Myers Squibb has announced the UK launch of Sprycel (dasatinib), its drug for the treatment of chronic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in